Metraipolis › archive › dc_375356a7ba72

Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review… — Europe PMC PMID:42523690

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42523690
DOI
10.3389/fonc.2026.1859759
License (as archived)
solo-consultazione
Archived
2026-10-18T07:02:25.303Z
SHA-256 of the archived text
211032de11733f6ed987e4f6dd497b81a602e7ffe76d5baec1851a80cfb5d0d0
Stable URL of this page
https://metraipolis.com/documento/dc_375356a7ba72

How to cite

Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review… — Europe PMC PMID:42523690 — Europe PMC (en), https://europepmc.org/article/MED/42523690 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_375356a7ba72 (Metraipolis archive dc_375356a7ba72, sha256 211032de11733f6ed987e4f6dd497b81a602e7ffe76d5baec1851a80cfb5d0d0)
BibTeX
@misc{dc375356a7ba72,
  title = {Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review… — Europe PMC PMID:42523690},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42523690},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_375356a7ba72; sha256 211032de11733f6ed987e4f6dd497b81a602e7ffe76d5baec1851a80cfb5d0d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42523690. Agents can read the archived copy with the MCP tool read_document.